Skip to main content
SpringerLink
Log in

Future Perspectives of Botulinum Toxin Application in Dentistry

  • Chapter
  • First Online:
Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine

  • 450 Accesses

Abstract

In recent years, the therapeutic application of botulinum neurotoxin (BoNT) has expanded to encompass a variety of issues beyond its well-known usage for hyperkinetic movement disorders, autonomic hyperactivity, and facial rejuvenation. Dentistry is one of the fields that has benefited greatly from botulinum toxin therapy, as evidenced by multiple clinical trials which provided evidence for usefulness of this mode of therapy in common issues encountered in the field of dentistry (described in Chap. 16). In this chapter, the future potentials for BoNT therapy in the field of dentistry and its use in oral and maxillofacial region with its rich network of nerves and muscles are described. In addition, this chapter focuses on preclinical and preliminary studies on the effect of intramuscular injections of BoNT on craniofacial growth and proposes the possibility of using this toxin to influence the dentofacial complex during growth. Existing data or suggestions on the use of BoNT in implant dentistry, tongue thrust, temporomandibular joint dislocation, bone/plate fractures, herpes simplex virus, angular cheilitis, and burning mouth syndrome are also presented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shah AA, Sandler J. Limiting factors in orthodontic treatment: 1. Factors related to patient, operator and orthodontic appliances. Dent Update. 2006;33(1):43–4, 46-8, 51-2.

    Article  Google Scholar 

  2. Haas Junior OL, Guijarro-Martínez R, de Sousa Gil AP, da Silva Meirelles L, Scolari N, Muñoz-Pereira ME, Hernández-Alfaro F, de Oliveira RB. Hierarchy of surgical stability in orthognathic surgery: overview of systematic reviews. Int J Oral Maxillofac Surg. 2019;48(11):1415–33. https://doi.org/10.1016/j.ijom.2019.03.003.

    Article  CAS  PubMed  Google Scholar 

  3. Hwang WS, Hur MS, Hu KS, Song WC, Koh KS, Baik HS, Kim ST, Kim HJ, Lee KJ. Surface anatomy of the lip elevator muscles for the treatment of gummy smile using botulinum toxin. Angle Orthod. 2009;79(1):70–7. https://doi.org/10.2319/091407-437.1.

    Article  PubMed  Google Scholar 

  4. Polo M. Botulinum toxin type A in the treatment of excessive gingival display. Am J Orthod Dentofac Orthop. 2005;127(2):214–8.

    Article  Google Scholar 

  5. Dilaver E, Uckan S. Effect of V-Y plasty on lip lengthening and treatment of gummy smile. Int J Oral Maxillofac Surg. 2018;47(2):184–7. https://doi.org/10.1016/j.ijom.2017.09.015.

    Article  CAS  PubMed  Google Scholar 

  6. Peck S, Peck L, Kataja M. The gingival smile line. Angle Orthod. 1992;62(2):91–100; discussion 101-2.

    CAS  PubMed  Google Scholar 

  7. Litton C, Fournier P. Simple surgical correction of the gummy smile. Plast Reconstr Surg. 1979;63:372–3.

    Article  CAS  Google Scholar 

  8. Miskinyar SA. A new method for correcting a gummy smile. Plast Reconstr Surg. 1983;72:397–400.

    Article  CAS  Google Scholar 

  9. Ellenbogen R. Correspondence and brief communications. Plast Reconstr Surg. 1984;73:697–8.

    Article  Google Scholar 

  10. Rees TD, LaTrenta GS. The long face syndrome and rhinoplasty. Persp Plast Surg. 1989;3:116.

    Google Scholar 

  11. Ezquerra F, Berrazueta MJ, Ruiz-Capillas A, Sainz-Arregui J. New approach to the gummy smile. Plast Reconstr Surg. 1999;104:1143–50.

    Article  CAS  Google Scholar 

  12. Mazzuco R, Hexsel D. Gummy smile and botulinum toxin: a new approach based on the gingival exposure area. J Am Acad Dermatol. 2010;63(6):1042–51. https://doi.org/10.1016/j.jaad.2010.02.053.

    Article  CAS  PubMed  Google Scholar 

  13. Duruel O, Ataman-Duruel ET, Berker E, Tözüm TF. Treatment of various types of gummy smile with botulinum toxin-A. J Craniofac Surg. 2019;30(3):876–8. https://doi.org/10.1097/SCS.0000000000005298.

    Article  PubMed  Google Scholar 

  14. Al Wayli H. Versatility of botulinum toxin at the Yonsei point for the treatment of gummy smile. Int J Esthet Dent. 2019;14(1):86–95.

    PubMed  Google Scholar 

  15. Duruel O, Ataman-Duruel ET, Tözüm TF, Berker E. Ideal dose and injection site for gummy smile treatment with botulinum toxin-A: a systematic review and introduction of a case study. Int J Periodontics Restorative Dent. 2019;39(4):e167–73. https://doi.org/10.11607/prd.3580.

    Article  PubMed  Google Scholar 

  16. Araujo JP, Cruz J, Oliveira JX, Canto AM. Botulinum toxin type-A as an alternative treatment for gummy smile: a case report. Dermatol Online J. 2018;24(7). pii: 13030/qt75f0h8kz

    Google Scholar 

  17. Sucupira E, Abramovitz A. A simplified method for smile enhancement: botulinum toxin injection for gummy smile. Plast Reconstr Surg. 2012;130(3):726–8. https://doi.org/10.1097/PRS.0b013e31825dc32f.

    Article  CAS  PubMed  Google Scholar 

  18. Polo M. Botulinum toxin type A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummy smile). Am J Orthod Dentofac Orthop. 2008;133(2):195–203. https://doi.org/10.1016/j.ajodo.2007.04.033.

    Article  Google Scholar 

  19. Al-Fouzan AF, Mokeem LS, Al-Saqat RT, Alfalah MA, Alharbi MA, Al-Samary AE. Botulinum toxin for the treatment of gummy smile. J Contemp Dent Pract. 2017;18(6):474–8.

    Article  Google Scholar 

  20. Suber JS, Dinh TP, Prince MD, Smith PD. OnabotulinumtoxinA for the treatment of a "gummy smile". Aesthet Surg J. 2014;34(3):432–7. https://doi.org/10.1177/1090820X14527603.

    Article  PubMed  Google Scholar 

  21. Nasr MW, Jabbour SF, Sidaoui JA, Haber RN, Kechichian EG. Botulinum toxin for the treatment of excessive gingival display: a systematic review. Aesthet Surg J. 2016;36(1):82–8. https://doi.org/10.1093/asj/sjv082.

    Article  PubMed  Google Scholar 

  22. Chagas TF, Almeida NV, Lisboa CO, Ferreira DMTP, Mattos CT, Mucha JN. Duration of effectiveness of Botulinum toxin type A in excessive gingival display: a systematic review and meta-analysis. Braz Oral Res. 2018;32:e30. https://doi.org/10.1590/1807-3107bor-2018.vol32.0030.

    Article  PubMed  Google Scholar 

  23. Seixas MR, Costa-Pinto RA, de Araújo TM. Checklist of aesthetic features to consider in diagnosing and treating excessive gingival display (gummy smile). Dent Press J Orthod. 2011;16(2):131–57. https://doi.org/10.1590/S2176-94512011000200016.

    Article  Google Scholar 

  24. Few JW Jr. Commentary on: gummy smile treatment: proposal for a novel corrective technique and a review of the literature. Aesthet Surg J. 2018;38(12):1339–40. https://doi.org/10.1093/asj/sjy220.

    Article  PubMed  Google Scholar 

  25. Mostafa D. A successful management of sever gummy smile using gingivectomy and botulinum toxin injection: a case report. Int J Surg Case Rep. 2018;42:169–74. https://doi.org/10.1016/j.ijscr.2017.11.055.

    Article  PubMed  Google Scholar 

  26. Chen G, Oranges CM, Giordano S, Huang R, Wang W. Horizontal animation deformity as unusual complication of neurotoxin modulation of the gummy smile. Dermatol Online J. 2019;25(8). pii: 13030/qt49s9h9zh

    Google Scholar 

  27. Pedron IG. Comment on “Botulinum toxin type-A as an alternative treatment for gummy smile: a case report”. Dermatol Online J. 2019;25(6). pii: 13030/qt1qk3183b

    Google Scholar 

  28. Polo M. Commentary on: botulinum toxin for the treatment of excessive gingival display: a systematic review. Aesthet Surg J. 2016;36(1):89–92. https://doi.org/10.1093/asj/sjv126.

    Article  PubMed  Google Scholar 

  29. Coclici A, Hedeşiu M, Bran S, Băciuţ M, Dinu C, Rotaru H, Roman R. Early and long-term changes in the muscles of the mandible following orthognathic surgery. Clin Oral Investig. 2019;23(9):3437–44. https://doi.org/10.1007/s00784-019-03019-3.

    Article  PubMed  Google Scholar 

  30. Seok H, Kim SG. Correction of malocclusion by botulinum neurotoxin injection into masticatory muscles. Toxins (Basel). 2018;10(1). pii: E27 https://doi.org/10.3390/toxins10010027.

  31. Shin SH, Kang YJ, Kim SG. The effect of botulinum toxin-A injection into the masseter muscles on prevention of plate fracture and post-operative relapse in patients receiving orthognathic surgery. Maxillofac Plast Reconstr Surg. 2018;40(1):36. https://doi.org/10.1186/s40902-018-0174-0. eCollection 2018 Dec.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kang YJ, Cha BK, Choi DS, Jang IS, Kim SG. Botulinum toxin-A injection into the anterior belly of the digastric muscle for the prevention of post-operative open bite in class II malocclusions: a case report and literature review. Maxillofac Plast Reconstr Surg. 2019;41(1):17. https://doi.org/10.1186/s40902-019-0201-9. eCollection 2019 Dec

    Article  PubMed  PubMed Central  Google Scholar 

  33. Seok H, Park YT, Kim SG, Park YW. Correction of post-traumatic anterior open bite by injection of botulinum toxin type A into the anterior belly of the digastric muscle: case report. J Korean Assoc Oral Maxillofac Surg. 2013;39(4):188–92.

    Article  Google Scholar 

  34. Mücke T, Löffel A, Kanatas A, Karnezi S, Rana M, Fichter A, Haarmann S, Wolff KD, Loeffelbein DJ. Botulinum toxin as a therapeutic agent to prevent relapse in deep bite patients. J Craniomaxillofac Surg. 2016;44(5):584–9. https://doi.org/10.1016/j.jcms.2016.01.021.

    Article  PubMed  Google Scholar 

  35. Luo M, Yang X, Wang Q, Li C, Yin Y, Han X2. Skeletal stability following bioresorbable versus titanium fixation in orthognathic surgery: a systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2018;47(2):141–51. https://doi.org/10.1016/j.ijom.2017.09.013.

    Article  CAS  PubMed  Google Scholar 

  36. Reid RR. Facial skeletal growth and timing of surgical intervention. Clin Plast Surg. 2007;34(3):357–67.

    Article  Google Scholar 

  37. Carlson DS. Theories of craniofacial growth in the postgenomic era. Semin Orthod. 2005;11(4):172–83.

    Article  Google Scholar 

  38. Castaldo G, Cerritelli F. Craniofacial growth: evolving paradigms. Cranio. 2015;33(1):23–31. https://doi.org/10.1179/0886963414Z.00000000042.

    Article  PubMed  Google Scholar 

  39. Alam, M. 2011, A to Z orthodontics. Volume 11: functional orthodontic appliance (Kota Bharu: PPSP Publication).

    Google Scholar 

  40. McNamara JA Jr, Huge SA. The functional regulator (FR-3) of Fränkel. Am J Orthod. 1985;88(5):409–24.

    Article  Google Scholar 

  41. Werner SP, Shivapuja PK, Harris EF. Skeletodental changes in the adolescent accruing from use of the lip bumper. Angle Orthod. 1994;64(1):13–20; discussion 21-2.

    CAS  PubMed  Google Scholar 

  42. Huang GJ, Justus R, Kennedy DB, Kokich VG. Stability of anterior openbite treated with crib therapy. Angle Orthod. 1990;60(1):17–24; discussion 25-6.

    CAS  PubMed  Google Scholar 

  43. Kurabeishi H, Tatsuo R, Makoto N, Kazunori F. Relationship between tongue pressure and maxillofacial morphology in Japanese children based on skeletal classification. J Oral Rehabil. 2018;45(9):684–91. https://doi.org/10.1111/joor.12680.

    Article  CAS  PubMed  Google Scholar 

  44. Hansen SE. The influence of genotype and perioral musculature on maxillary and mandibular development [dissertation]. Pittsburgh Univ; 2018.

    Google Scholar 

  45. Alabdullah M, Saltaji H, Abou-Hamed H, Youssef M. Association between facial growth pattern and facial muscle activity: a prospective cross-sectional study. Int Orthod. 2015;13(2):181–94. https://doi.org/10.1016/j.ortho.2015.03.011.

    Article  PubMed  Google Scholar 

  46. Babuccu B, Babuccu O, Yurdakan G, Ankarali H. The effect of the Botulinum toxin-A on craniofacial development: an experimental study. Ann Plast Surg. 2009;63(4):449–56. https://doi.org/10.1097/SAP.0b013e31818d4559.

    Article  CAS  PubMed  Google Scholar 

  47. Ahn J, Kim SG, Kim MK, Jang I, Seok H. Botulinum toxin A injection into the anterior belly of the digastric muscle increased the posterior width of the maxillary arch in developing rats. Maxillofac Plast Reconstr Surg. 2019;41(1):20. https://doi.org/10.1186/s40902-019-0203-7. eCollection 2019 Dec.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Tsai CY, Wang CW, Chang CW. Effects of masticatory muscle function affected by BTX on maxillofacial bone growth through the sutural modification. Orthod Craniofac Res. 2019;22(2):112–7. https://doi.org/10.1111/ocr.12290.

    Article  PubMed  Google Scholar 

  49. Tsai CY, Shyr YM, Chiu WC, Lee CM. Bone changes in the mandible following botulinum neurotoxin injections. Eur J Orthod. 2011;33(2):132–8. https://doi.org/10.1093/ejo/cjq029.

    Article  PubMed  Google Scholar 

  50. Kim JY, Kim ST, Cho SW, Jung HS, Park KT, Son HK. Growth effects of botulinum toxin type A injected into masseter muscle on a developing rat mandible. Oral Dis. 2008;14(7):626–32. https://doi.org/10.1111/j.1601-0825.2007.01435.x.

    Article  PubMed  Google Scholar 

  51. Park C, Park K, Kim J. Growth effects of botulinum toxin type A injected unilaterally into the masseter muscle of developing rats. J Zhejiang Univ Sci B. 2015;16(1):46–51. https://doi.org/10.1631/jzus.B1400192.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Tsai CY, Chiu WC, Liao YH, Tsai CM. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle. Am J Orthod Dentofac Orthop. 2009;135(2):142.e1–6; discussion 142-3. https://doi.org/10.1016/j.ajodo.2008.06.020.

    Article  Google Scholar 

  53. Seok H, Kim SG, Kim MK, Jang I, Ahn J. Effect of the masseter muscle injection of botulinum toxin A on the mandibular bone growth of developmental rats. Maxillofac Plast Reconstr Surg. 2018;40(1):5. https://doi.org/10.1186/s40902-018-0146-4. eCollection 2018 Dec.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Choi JW, Kim HJ, Moon JW, Kang SH, Tak HJ, Lee SH. Compensatory dentoalveolar supraeruption and occlusal plane cant after botulinum-induced hypotrophy of masticatory closing muscles in juvenile rats. Arch Oral Biol. 2019;101:34–42. https://doi.org/10.1016/j.archoralbio.2019.03.003.

    Article  PubMed  Google Scholar 

  55. Kahn A, Kün-Darbois JD, Bertin H, Corre P, Chappard D. Mandibular bone effects of botulinum toxin injections in masticatory muscles in adult. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019. pii: S2212-4403(19)30397-9; https://doi.org/10.1016/j.oooo.2019.03.007.

  56. Raphael KG, Tadinada A, Bradshaw JM, Janal MN, Sirois DA, Chan KC, Lurie AG. Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study. J Oral Rehabil. 2014;41(8):555–63. https://doi.org/10.1111/joor.12180.

    Article  CAS  PubMed  Google Scholar 

  57. Lee HJ, Kim SJ, Lee KJ, Yu HS, Baik HS. Repeated injections of botulinum toxin into the masseter muscle induce bony changes in human adults: a longitudinal study. Korean J Orthod. 2017;47(4):222–8. https://doi.org/10.4041/kjod.2017.47.4.222.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Chang CS, Bergeron L, Yu CC, Chen PK, Chen YR. Mandible changes evaluated by computed tomography following Botulinum Toxin A injections in square-faced patients. Aesthet Plast Surg. 2011;35(4):452–5. https://doi.org/10.1007/s00266-010-9624-5.

    Article  CAS  Google Scholar 

  59. Savarese R, Diamond M, Elovic E, Millis SR. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am J Phys Med Rehabil. 2004;83(4):304–11; quiz 312-4, 336.

    Article  Google Scholar 

  60. Calim OF, Hassouna HNH, Yildirim YS, Dogan R, Ozturan O. Pediatric Sialorrhea: submandibular duct rerouting and intraparotid botulinum toxin A injection with literature review. Ann Otol Rhinol Laryngol. 2019;128(2):104–12. https://doi.org/10.1177/0003489418808305.

    Article  PubMed  Google Scholar 

  61. Shogan AN, Rogers DJ, Hartnick CJ, Kerschner JE. Use of botulinum toxin in pediatric otolaryngology and laryngology. Int J Pediatr Otorhinolaryngol. 2014;78(9):1423–5. https://doi.org/10.1016/j.ijporl.2014.06.026.

    Article  PubMed  Google Scholar 

  62. Rowe FJ, Noonan CP. Botulinum toxin for the treatment of strabismus. Cochrane Database Syst Rev. 2017;3:CD006499. https://doi.org/10.1002/14651858.CD006499.pub4.

    Article  PubMed  Google Scholar 

  63. Akbay E, Cevik C, Damlar I, Altan A. Treatment of displaced mandibular condylar fracture with botulinum toxin A. Auris Nasus Larynx. 2014;41(2):219–21. https://doi.org/10.1016/j.anl.2013.08.002.

    Article  PubMed  Google Scholar 

  64. Ali SS, Bragin I, Rende E, Mejico L, Werner KE. Further evidence that Onabotulinum toxin is a viable treatment option for pediatric chronic migraine patients. Cureus. 2019;11(3):e4343. https://doi.org/10.7759/cureus.4343.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Cho YM, Kim SG, Choi DS, Jang I, Cha BK. Botulinum toxin injection to treat masticatory movement disorder corrected mandibular asymmetry in a growing patient. J Craniofac Surg. 2019; https://doi.org/10.1097/SCS.0000000000005606.

  66. Wishney M, Darendeliler MA, Dalci O. Myofunctional therapy and prefabricated functional appliances: an overview of the history and evidence. Aust Dent J. 2019;64(2):135–44. https://doi.org/10.1111/adj.12690.

    Article  CAS  PubMed  Google Scholar 

  67. Bucci R, Koutris M, Lobbezoo F, Michelotti A. Occlusal sensitivity in individuals with different frequencies of oral parafunction. J Prosthet Dent. 2019;122(2):119–22. https://doi.org/10.1016/j.prosdent.2018.10.006.

    Article  PubMed  Google Scholar 

  68. Resnik RR, Misch CE. Treatment planning complications. In: Misch's avoiding complications in oral implantology, vol. 1: Mosby; 2018. p. 54–147. https://doi.org/10.1016/B978-0-323-37580-1.00003-2.

  69. Kwon KH, Shin KS, Yeon SH, Kwon DG. Application of botulinum toxin in maxillofacial field: part III. Ancillary treatment for maxillofacial surgery and summary. Maxillofac Plast Reconstr Surg. 2019;41(1):45. https://doi.org/10.1186/s40902-019-0226-0. eCollection 2019 Dec

    Article  PubMed  PubMed Central  Google Scholar 

  70. Manfredini D, Poggio CE, Lobbezoo F. Is bruxism a risk factor for dental implants? A systematic review of the literature. Clin Implant Dent Relat Res. 2014;16(3):460–9. https://doi.org/10.1111/cid.12015.

    Article  PubMed  Google Scholar 

  71. Mijiritsky E, Mortellaro C, Rudberg O, Fahn M, Basegmez C, Levin L. Botulinum toxin type A as preoperative treatment for immediately loaded dental implants placed in fresh extraction sockets for full-arch restoration of patients with bruxism. J Craniofac Surg. 2016;27(3):668–70. https://doi.org/10.1097/SCS.0000000000002566.

    Article  PubMed  Google Scholar 

  72. Yilmaz C, Dogan A, Kizilaslan S, Gültekin A, Ersanli S. Botulinum toxin type a usage for preoperative treatment for dental implants placed in maxillary arches for full-arch restoration of patients with bruxism. Clin Oral Impl Res. 2017;28(S14):193. https://doi.org/10.1111/clr.192_13042.

    Article  Google Scholar 

  73. Malcmacher L, Kosinski T. Bruxism, Botox, and dental implants. Dent Today. 2017;36(4):94. 96-7

    PubMed  Google Scholar 

  74. Ihde S. Utilisation prophylactique de la toxine botulique en implantologie dentaire. Implantodontie. 2005;14(2):51–5.

    Article  Google Scholar 

  75. Ihde S. Utilisation thérapeutique de la toxine botulique dans le traitement d'entretien en implantologie dentaire. Implantodontie. 2005;14(2):56–61.

    Article  Google Scholar 

  76. Ihde SKA, Konstantinovic VS. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:e1–e11.

    Article  Google Scholar 

  77. Freund B, Bongard S, Zarb JP, Jones C. Full arch implant rehabilitation: parafunctional problems and solutions: https://www.oralhealthgroup.com/features/full-arch-implant-rehabilitation-parafunctional-problems-and-solutions/

  78. Law CS, Habits O. In: Nowak AJ, Christensen JR, Mabry TR, Townsend JA, Wells MH, editors. Pediatric dentistry: infancy through adolescence. 6th ed. Philadelphia: Saunders; 2019. p. 386–393.e2.

    Google Scholar 

  79. Dean JA. Managing the developing occlusion. In: McDonald and Avery’s dentistry for the child and adolescent. 10th ed. St. Louis: Elsevier Publication; 2016. p. 415–78.

    Chapter  Google Scholar 

  80. Taslan S, Biren S, Ceylanoglu C. Tongue pressure changes before, during and after crib appliance therapy. Angle Orthod. 2010;80(3):533–9. https://doi.org/10.2319/070209-370.1.

    Article  PubMed  Google Scholar 

  81. Laskawi R. The use of botulinum toxin in head and face medicine: an interdisciplinary field. Head Face Med. 2008;4:5. https://doi.org/10.1186/1746-160X-4-5.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Yoshida K. Botulinum neurotoxin therapy for lingual dystonia using an individualized injection method based on clinical features. Toxins (Basel). 2019;11(1). pii: E51 https://doi.org/10.3390/toxins11010051.

  83. Muñoz Lora VRM, Del Bel Cury AA, Jabbari B, Lacković Z. Botulinum toxin type A in dental medicine. J Dent Res. 2019;98(13):1450–7. https://doi.org/10.1177/0022034519875053.

    Article  CAS  PubMed  Google Scholar 

  84. Safarpour Y. Jabbari 2.Botulinum toxin treatment of pain syndromes -an evidence based review. Toxicon. 2018;147:120–8. https://doi.org/10.1016/j.toxicon.2018.01.017.

    Article  CAS  PubMed  Google Scholar 

  85. Gassner HG, Brissett AE, Otley CC, Boahene DK, Boggust AJ, Weaver AL, Sherris DA. Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study. Mayo Clin Proc. 2006;81(8):1023–8.

    Article  CAS  Google Scholar 

  86. Kim SH, Lee SJ, Lee JW, Jeong HS, Suh IS. Clinical trial to evaluate the efficacy of botulinum toxin type a injection for reducing scars in patients with forehead laceration: a double-blinded, randomized controlled study. Medicine (Baltimore). 2019;98(34):e16952. https://doi.org/10.1097/MD.0000000000016952.

    Article  CAS  Google Scholar 

  87. Wang Y, Wang J, Zhang J, Hu C, Zhu F. Effectiveness and safety of botulinum toxin type A injection for scar prevention: a systematic review and meta-analysis. Aesthet Plast Surg. 2019;43(5):1241–9. https://doi.org/10.1007/s00266-019-01358-w.

    Article  Google Scholar 

  88. Abrahamsson H, Eriksson L, Abrahamsson P, Häggman-Henrikson B. Treatment of temporomandibular joint luxation: a systematic literature review. Clin Oral Investig. 2019; https://doi.org/10.1007/s00784-019-03126-1.

  89. Szkutnik J, Wójcicki M, Berger M, Bakalczuk M, Litko M, Łobacz M, Rahnama-Hezavah M. Treatment of habitual luxation of temporomandibular joint – literature review. Eur J Med Technol. 2018;2(19):17–21.

    Google Scholar 

  90. Elledge ROC, Speculand B. Conservative management options for dislocation of the temporomandibular joint. In: Matthews N, editor. Dislocation of the temporomandibular joint. Cham: Springer; 2018.

    Google Scholar 

  91. Prechel U, Ottl P, Ahlers OM, Neff A. The treatment of temporomandibular joint dislocation. Dtsch Arztebl Int. 2018;115(5):59–64. https://doi.org/10.3238/arztebl.2018.0059.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Yoshida K. Botulinum neurotoxin injection for the treatment of recurrent temporomandibular joint dislocation with and without neurogenic muscular hyperactivity. Toxins (Basel). 2018;10(5). pii: E174 https://doi.org/10.3390/toxins10050174.

  93. Ziegler CM, Haag C, Mühling J. Treatment of recurrent temporomandibular joint dislocation with intramuscular botulinum toxin injection. Clin Oral Investig. 2003;7(1):52–5.

    Article  Google Scholar 

  94. Vázquez Bouso O, Forteza González G, Mommsen J, Grau VG, Rodríguez Fernández J, Mateos Micas M. Neurogenic temporomandibular joint dislocation treated with botulinum toxin: report of 4 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(3):e33–7. https://doi.org/10.1016/j.tripleo.2009.10.046.

    Article  PubMed  Google Scholar 

  95. Daelen B, Thorwirth V, Koch A. Treatment of recurrent dislocation of the temporomandibular joint with type a botulinum toxin. Int J Oral Maxillofac Surg. 1997;26(6):458–60.

    Article  CAS  Google Scholar 

  96. Martínez-Pérez D, García Ruiz-Espiga P. Recurrent temporomandibular joint dislocation treated with botulinum toxin: report of 3 cases. J Oral Maxillofac Surg. 2004;62(2):244–6.

    Article  Google Scholar 

  97. Stark TR, Perez CV, Okeson JP, Recurrent TMJ. Dislocation managed with botulinum toxin type A injections in a pediatric patient. Pediatr Dent. 2015;37(1):65–9.

    PubMed  Google Scholar 

  98. Moore AP, Wood GD. Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A. Br Dent J. 1997;183(11-12):415–7.

    Article  CAS  Google Scholar 

  99. Fu KY, Chen HM, Sun ZP, Zhang ZK, Ma XC. Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint. Br J Oral Maxillofac Surg. 2010;48(4):281–4. https://doi.org/10.1016/j.bjoms.2009.07.014.

    Article  PubMed  Google Scholar 

  100. Oztel M, Bilski WM, Bilski A. Botulinum toxin used to treat recurrent dislocation of the temporomandibular joint in a patient with osteoporosis. Br J Oral Maxillofac Surg. 2017;55(1):e1–2. https://doi.org/10.1016/j.bjoms.2016.05.012.

    Article  PubMed  Google Scholar 

  101. Shehata B, Darwish S, Aly T, Younis G. Treatment of recurrent temporomandibular joint dislocation with botulinum toxin. Alex Dent J. 2015;40(2):200–7. https://doi.org/10.21608/adjalexu.2015.59152.

    Article  Google Scholar 

  102. Renapurkar SK, Laskin DM. Injectable agents versus surgery for recurrent temporomandibular joint dislocation. Oral Maxillofac Surg Clin North Am. 2018;30(3):343–9. https://doi.org/10.1016/j.coms.2018.04.009.

    Article  PubMed  Google Scholar 

  103. Altaweel AA, Elsayed SA, Baiomy AABA, Abdelsadek SE, Hyder AA. Extraoral versus intraoral botulinum toxin type A injection for management of temporomandibular joint disc displacement with reduction. J Craniofac Surg. 2019;30(7):2149–53. https://doi.org/10.1097/SCS.0000000000005658.

    Article  PubMed  Google Scholar 

  104. Shorey CW, Campbell JH. Dislocation of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89(6):662–8.

    Article  CAS  Google Scholar 

  105. Odono LT, Brady CM, Urata M. Mandible fractures. In: Facial trauma surgery; 2020. p. 168–85). Content Repository Only! https://doi.org/10.1016/B978-0-323-49755-8.00022-0.

    Chapter  Google Scholar 

  106. Aydin A, Memisoglu K, Cengiz A, Atmaca H, Muezzinoglu B, Muezzinoglu US. Effects of botulinum toxin A on fracture healing in rats: an experimental study. J Orthop Sci. 2012;17(6):796–801. https://doi.org/10.1007/s00776-012-0269-x.

    Article  CAS  PubMed  Google Scholar 

  107. Hao Y, Ma Y, Wang X, Jin F, Ge S. Short-term muscle atrophy caused by botulinum toxin-A local injection impairs fracture healing in the rat femur. J Orthop Res. 2012;30(4):574–80. https://doi.org/10.1002/jor.21553.

    Article  CAS  PubMed  Google Scholar 

  108. Canter HI, Kayikcioglu A, Aksu M, Mavili ME. Botulinum toxin in closed treatment of mandibular condylar fracture. Ann Plast Surg. 2007;58(5):474–8.

    Article  CAS  Google Scholar 

  109. Kayikçioğlu A, Erk Y, Mavili E, Vargel I, Ozgür F. Botulinum toxin in the treatment of zygomatic fractures. Plast Reconstr Surg. 2003;111(1):341–6.

    Article  Google Scholar 

  110. Miranda-Saksena M, Boadle RA, Aggarwal A, Tijono B, Rixon FJ, Diefenbach RJ, Cunningham AL. Herpes simplex virus utilizes the large secretory vesicle pathway for anterograde transport of tegument and envelope proteins and for viral exocytosis from growth cones of human fetal axons. J Virol. 2009;83(7):3187–99. https://doi.org/10.1128/JVI.01579-08.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Petti S, Lodi G. The controversial natural history of oral herpes simplex virus type 1 infection. Oral Dis. 2019; https://doi.org/10.1111/odi.13234.

  112. Gilbert E, Zhu J, Peng T, Ward NL. Decreased labial herpes simplex virus outbreaks following botulinum neurotoxin type A injection: a case report. J Drugs Dermatol. 2018;17(10):1127–9.

    PubMed  Google Scholar 

  113. Narang P, Singh S, Mittal V. Bilateral herpes simplex keratitis reactivation after lacrimal gland botulinum toxin injection. Indian J Ophthalmol. 2018;66(5):697–9. https://doi.org/10.4103/ijo.IJO_904_17.

    Article  PubMed  PubMed Central  Google Scholar 

  114. Ramappa M, Jiya PY, Chaurasia S, Naik M, Sharma S. Reactivation of herpes simplex viral keratitis following the botulinum toxin injection. Indian J Ophthalmol. 2018;66(2):306–8. https://doi.org/10.4103/ijo.IJO_714_17.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Graber EM, Dover JS, Arndt KA. Two cases of herpes zoster appearing after botulinum toxin type a injections. J Clin Aesthet Dermatol. 2011;4(10):49–51.

    PubMed  PubMed Central  Google Scholar 

  116. Federico JR, Basehore BM, Zito PM. Angular Chelitis. [Updated 2019 Aug 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019. Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK536929/.

  117. Katz H, Blumenfeld A, inventors; Allergan Inc, assignee. Botulinum toxin dental therapy for angular cheilosis. United States patent application US 11/029,546. 2006.

    Google Scholar 

  118. Bae GY, Na JI, Park KC, Cho SB. Nonsurgical correction of drooping mouth corners using monophasic hyaluronic acid and incobotulinumtoxinA. J Cosmet Dermatol. 2019; https://doi.org/10.1111/jocd.13010.

  119. Kwon CI, Shin YB, Jo JW, Jeong HB, Moon YS, Jung EC, Kim CY, Yoon TJ. P272: A case of angular cheilitis treated with botulinum toxin. Program Book (Old Green Collection). 2018;70(1):413.

    Google Scholar 

  120. Bender SD. Burning Mouth Syndrome. Dent Clin N Am. 2018;62(4):585–96. https://doi.org/10.1016/j.cden.2018.05.006.

    Article  PubMed  Google Scholar 

  121. Restivo DA, Lauria G, Marchese-Ragona R, Vigneri R. Botulinum Toxin for Burning Mouth Syndrome. Ann Intern Med. 2017;166(10):762–3. https://doi.org/10.7326/L16-0451.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Shahroo Etemad-Moghadam

Authors
  1. Shahroo Etemad-Moghadam
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Professor Emeritus of Neurology, Yale University School of Medicine, New Haven, CT, USA

    Bahman Jabbari

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Etemad-Moghadam, S. (2020). Future Perspectives of Botulinum Toxin Application in Dentistry. In: Jabbari, B. (eds) Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-50691-9_18

Download citation

Publish with us

Policies and ethics

Search

Navigation